Oncotype Dx use and its relationship with chemotherapy administration in the general population

被引：0
|
作者：
Chavez-MacGregor, Mariana [1 ]
Niu, Jiangong [1 ]
Smith, Benjamin [1 ]
Zhao, Hui [1 ]
Buchholz, Thomas A. [1 ]
Giordano, Sharon H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Utilization of Oncotype DX to predict chemotherapy use in an inner-city population
    Guth, A. A.
    Fineberg, S.
    Fei, K.
    Franco, R.
    Bickell, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Relationship between Oncotype DX testing and the use of chemotherapy in high-risk patients (pts).
    Wong, Winston
    Cooper, Joseph
    Richardson, Steve
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Evaluation of relation between Oncotype DX recurrence score and adjuvant chemotherapy administration
    Kazzaz, D. R.
    Chen, C.
    Shankleton, J.
    Forsyth, M. T.
    Ganesh, R.
    Sims, M.
    Patt, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Oncotype DX testing and differences in use of chemotherapy by age in an integrated system
    Aller, Ashley
    Lyon, Liisa
    Habel, Laurel
    Shirazi, Aida
    Liu, Raymond
    CANCER RESEARCH, 2024, 84 (06)
  • [5] The Warwick Experience of the Oncotype DX® Breast Recurrence Score® Assay as a Predictor of Chemotherapy Administration
    Khan, Mashuk Alam
    Henderson, Laura
    Clarke, Dayalan
    Harries, Simon
    Jones, Lucie
    BREAST CARE, 2018, 13 (05) : 369 - 372
  • [6] Patterns of oncotype DX testing and adjuvant chemotherapy use in a tertiary care centre
    Sudan, Gautam
    Mates, Mihaela
    Wilma, Hopman
    CANCER RESEARCH, 2015, 75
  • [7] Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
    Jeffrey G. Schneider
    Danny N. Khalil
    Breast Cancer Research and Treatment, 2012, 134 : 1125 - 1132
  • [8] Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
    Schneider, Jeffrey G.
    Khalil, Danny N.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1125 - 1132
  • [9] Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
    Press, David J.
    Ibraheem, Abiola
    Dolan, M. Eileen
    Goss, Kathleen H.
    Conzen, Suzanne
    Huo, Dezheng
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 207 - 220
  • [10] Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
    David J. Press
    Abiola Ibraheem
    M. Eileen Dolan
    Kathleen H. Goss
    Suzanne Conzen
    Dezheng Huo
    Breast Cancer Research and Treatment, 2018, 168 : 207 - 220
12345